Literature DB >> 10474906

NMR diffusion and relaxation study of drug-protein interaction.

R S Luo, M L Liu, X A Mao.   

Abstract

In this work, NMR diffusion and relaxation measurements are applied to the study of the interaction between the anti-inflammatory drug salicylate and the human serum albumin (HSA) in solutions. The self-diffusion coefficients and the spin-lattice relaxation rates of salicylate are measured as a function of the concentration. The dissociation constant, Kd, for drug/HSA complexes and the number of binding sites, n, are evaluated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10474906     DOI: 10.1016/s1386-1425(99)00052-9

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  5 in total

1.  Study of non-covalent interactions between MRI contrast agents and human serum albumin by NMR diffusometry.

Authors:  C Henoumont; L Vander Elst; S Laurent; Robert N Muller
Journal:  J Biol Inorg Chem       Date:  2009-02-25       Impact factor: 3.358

2.  NMR chemical shift study of the interaction of selected peptides with liposomal and micellar models of apoptotic cells.

Authors:  Aurore Van Koninckxloo; Céline Henoumont; Sophie Laurent; Robert N Muller; Luce Vander Elst
Journal:  J Biol Inorg Chem       Date:  2014-10-07       Impact factor: 3.358

3.  Spectroscopic investigations on the interactions of potent platinum(II) anticancer agents with bovine serum albumin.

Authors:  Anwen M Krause-Heuer; William S Price; Janice R Aldrich-Wright
Journal:  J Chem Biol       Date:  2012-05-11

4.  Screen anti-influenza lead compounds that target the PA(C) subunit of H5N1 viral RNA polymerase.

Authors:  Lin Li; Shenghai Chang; Junfeng Xiang; Qian Li; Huanhuan Liang; Yalin Tang; Yingfang Liu
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

5.  The effect of polyhydroxylated alkaloids on maltase-glucoamylase.

Authors:  Qian Shang; Junfeng Xiang; Hong Zhang; Qian Li; Yalin Tang
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.